Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Inflammatory bowel disease, past, present and future: lessons from animal models.

Mizoguchi A, Mizoguchi E.

J Gastroenterol. 2008;43(1):1-17. doi: 10.1007/s00535-007-2111-3. Epub 2008 Feb 24. Review.

PMID:
18297430
[PubMed - indexed for MEDLINE]
2.

Future of IBD pathogenesis: how much work is left to do?

Fiocchi C.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S145-7. doi: 10.1002/ibd.20659. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816721
[PubMed - indexed for MEDLINE]
3.

Immunopathogenesis of inflammatory bowel disease: current concepts.

Bamias G, Cominelli F.

Curr Opin Gastroenterol. 2007 Jul;23(4):365-9. Review.

PMID:
17545770
[PubMed - indexed for MEDLINE]
4.

Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

Kanai T, Nemoto Y, Kamada N, Totsuka T, Hisamatsu T, Watanabe M, Hibi T.

Curr Opin Gastroenterol. 2009 Jul;25(4):306-13. doi: 10.1097/MOG.0b013e32832bc627. Review.

PMID:
19448533
[PubMed - indexed for MEDLINE]
5.

[Inflammatory bowel diseases: an immunological approach].

Sepúlveda SE, Beltrán CJ, Peralta A, Rivas P, Rojas N, Figueroa C, Quera R, Hermoso MA.

Rev Med Chil. 2008 Mar;136(3):367-75. doi: /S0034-98872008000300014. Epub 2008 Jun 3. Review. Spanish.

PMID:
18575665
[PubMed - indexed for MEDLINE]
Free Article
6.

The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease.

Himmel ME, Hardenberg G, Piccirillo CA, Steiner TS, Levings MK.

Immunology. 2008 Oct;125(2):145-53. doi: 10.1111/j.1365-2567.2008.02939.x. Review.

PMID:
18798918
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand?

Fiocchi C.

Dig Dis. 2009;27(3):226-35. doi: 10.1159/000228554. Epub 2009 Sep 24. Review.

PMID:
19786745
[PubMed - indexed for MEDLINE]
8.

Clinical aspects of inflammatory bowel disease.

Siegmund B, Zeitz M.

Eur J Immunol. 2009 Aug;39(8):2026-30. doi: 10.1002/eji.200939601.

PMID:
19672897
[PubMed - indexed for MEDLINE]
9.

Regulatory T cells in inflammatory bowel disease.

Boden EK, Snapper SB.

Curr Opin Gastroenterol. 2008 Nov;24(6):733-41. Review.

PMID:
19125486
[PubMed - indexed for MEDLINE]
10.

Animal models of inflammatory bowel disease.

Mizoguchi A.

Prog Mol Biol Transl Sci. 2012;105:263-320. doi: 10.1016/B978-0-12-394596-9.00009-3. Review.

PMID:
22137435
[PubMed - indexed for MEDLINE]
11.

Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.

Liu Z, Yang L, Cui Y, Wang X, Guo C, Huang Z, Kan Q, Liu Z, Liu Y.

Inflamm Bowel Dis. 2009 Aug;15(8):1133-44. doi: 10.1002/ibd.20923.

PMID:
19322899
[PubMed - indexed for MEDLINE]
12.

CD4 T-cell differentiation and inflammatory bowel disease.

Zenewicz LA, Antov A, Flavell RA.

Trends Mol Med. 2009 May;15(5):199-207. doi: 10.1016/j.molmed.2009.03.002. Epub 2009 Apr 8. Review.

PMID:
19362058
[PubMed - indexed for MEDLINE]
13.

[Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].

Papp M.

Orv Hetil. 2008 Nov 30;149(48):2269-76. doi: 10.1556/OH.2008.28463. Hungarian.

PMID:
19028649
[PubMed - indexed for MEDLINE]
14.

Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory.

Levin A, Shibolet O.

World J Gastroenterol. 2008 Sep 7;14(33):5149-53. Review.

PMID:
18777591
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

[Inflammatory bowel disease: IBD].

Endo K, Shiga H, Kinouchi Y, Shimosegawa T.

Rinsho Byori. 2009 Jun;57(6):527-32. Review. Japanese.

PMID:
19621784
[PubMed - indexed for MEDLINE]
16.

Innate and adaptive immune responses related to IBD pathogenesis.

Arseneau KO, Tamagawa H, Pizarro TT, Cominelli F.

Curr Gastroenterol Rep. 2007 Dec;9(6):508-12. Review.

PMID:
18377804
[PubMed - indexed for MEDLINE]
17.

Future therapies for inflammatory bowel disease.

Bickston SJ, Comerford LW, Cominelli F.

Curr Gastroenterol Rep. 2003 Dec;5(6):518-23. Review.

PMID:
14602063
[PubMed - indexed for MEDLINE]
18.

Immunologic and molecular mechanisms in inflammatory bowel disease.

Ince MN, Elliott DE.

Surg Clin North Am. 2007 Jun;87(3):681-96. Review.

PMID:
17560420
[PubMed - indexed for MEDLINE]
19.

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.

Lakatos PL, Altorjay I, Szamosi T, Palatka K, Vitalis Z, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Barta Z, Stocker W, Papp J, Veres G, Papp M; Hungarian IBD Study Group.

Inflamm Bowel Dis. 2009 Mar;15(3):365-74. doi: 10.1002/ibd.20778.

PMID:
18972554
[PubMed - indexed for MEDLINE]
20.

GWA studies: rewriting the story of IBD.

Budarf ML, Labbé C, David G, Rioux JD.

Trends Genet. 2009 Mar;25(3):137-46. doi: 10.1016/j.tig.2009.01.001. Epub 2009 Feb 13. Review.

PMID:
19217684
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk